SCHEMBL6312949

SCHEMBL6312949

CCc1c(C2(O)CCNCC2)sc2ccccc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.38
CYP2D6 P10635 2/20 0.36
CYP1A2 P05177 2/20 0.36
TSHR P16473 1/20 0.36
NFKB1 P19838 1/20 0.36
HSD17B10 Q99714 1/20 0.36
FTO Q9C0B1 1/20 0.36
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
HPGD P15428 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
DRD2 P14416 1/20 0.33
SLC6A2 P23975 3/20 0.33
CNR2 P34972 2/20 0.33
OPRM1 P35372 2/20 0.33
NMT1 P30419 2/20 0.32
GPR3 P46089 1/20 0.32
CNR1 P21554 1/20 0.31
SLC6A4 P31645 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6311037 0.81 SIGMAR1 (0.41) SIGMAR1CYP2D6CYP1A2TSHRNFKB1
SCHEMBL6313007 0.70 MEN1 (0.43) SIGMAR1CYP2D6CYP1A2TSHRNFKB1
SCHEMBL256692 0.67 GPR3 (0.44) CYP2D6CYP1A2TSHRNFKB1HSD17B10
SCHEMBL14045624 0.65 CNR2 (0.46) CYP2D6CYP1A2TSHRNFKB1HSD17B10
SCHEMBL15450945 0.65 CYP1A2 (0.51) CYP2D6CYP1A2TSHRNFKB1HSD17B10
SCHEMBL11321079 0.64 NPY1R (0.49) CYP2D6ALDH1A1LMNACNR2GPR3
SCHEMBL20154912 0.64 GPR3 (0.41) CYP2D6CYP1A2TSHRNFKB1HSD17B10
SCHEMBL31691151 0.64 NPY1R (0.49) CYP2D6ALDH1A1LMNACNR2GPR3
Dibenzothiophene SCHEMBL28254130 0.63 GPR3 (0.70) CYP2D6CYP1A2TSHRNFKB1HSD17B10
SCHEMBL6311330 0.63 SIGMAR1 (0.44) SIGMAR1CYP2D6CYP1A2TSHRNFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6844344-B2 Benzofuran derivatives ELI LILLY AND COMPANY (US) 2005-01-18 US disclosed
US-6784180-B2 INHIBITING THE REUPTAKE OF SEROTONIN AND ANTAGONIZING THE 5-HT1A RECEPTOR; AS ANTIDEPRESSANT OR TO POTENTIATE EFFECTS OF ANOTHER SSRI ELI LILLY AND COMPANY 2004-08-31 US disclosed
EP-1250336-B1 PIPERIDINE DERIVATIVES AND THEIR USE AS SEROTONIN RECEPTOR ANTAGONISTS LILLY CO ELI (US) 2004-05-12 EP disclosed
US-20030232833-A1 Benzofuran derivatives ELI LILLY AND COMPANY 2003-12-18 US disclosed
US-20030225281-A1 Piperidines derivatives and their use as serotonin receptor antagonists ELI LILLY AND COMPANY 2003-12-04 US disclosed
EP-1250336-A1 PIPERIDINE DERIVATIVES AND THEIR USE AS SEROTONIN RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 2002-10-23 EP disclosed
WO-2001046179-A1 PIPERIDINE DERIVATIVES AND THEIR USE AS SEROTONIN RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 2001-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030225281-A1 Piperidines derivatives and their use as serotonin receptor antagonists HTR1A, HTR1D, HTR5A SIGMAR1 173/4885CYP2D6 1244/4885CYP1A2 532/4885
US-20030232833-A1 Benzofuran derivatives BRD1, BPTF, HTR1F SIGMAR1 789/4885CYP2D6 378/4885CYP1A2 162/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.